210 related articles for article (PubMed ID: 30604274)
1. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.
Nterma P; Panopoulou E; Papadaki-Petrou E; Assimakopoulou M
Pathol Oncol Res; 2020 Jan; 26(1):567-574. PubMed ID: 30604274
[TBL] [Abstract][Full Text] [Related]
2. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.
Matallanas D; Romano D; Yee K; Meissl K; Kucerova L; Piazzolla D; Baccarini M; Vass JK; Kolch W; O'neill E
Mol Cell; 2007 Sep; 27(6):962-75. PubMed ID: 17889669
[TBL] [Abstract][Full Text] [Related]
4. RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73.
Papaspyropoulos A; Bradley L; Thapa A; Leung CY; Toskas K; Koennig D; Pefani DE; Raso C; Grou C; Hamilton G; Vlahov N; Grawenda A; Haider S; Chauhan J; Buti L; Kanapin A; Lu X; Buffa F; Dianov G; von Kriegsheim A; Matallanas D; Samsonova A; Zernicka-Goetz M; O'Neill E
Nat Commun; 2018 Jan; 9(1):424. PubMed ID: 29382819
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.
Gordon M; El-Kalla M; Zhao Y; Fiteih Y; Law J; Volodko N; Anwar-Mohamed A; El-Kadi AO; Liu L; Odenbach J; Thiesen A; Onyskiw C; Ghazaleh HA; Park J; Lee SB; Yu VC; Fernandez-Patron C; Alexander RT; Wine E; Baksh S
PLoS One; 2013; 8(10):e75483. PubMed ID: 24146755
[TBL] [Abstract][Full Text] [Related]
6. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
[TBL] [Abstract][Full Text] [Related]
7. Methylation‑associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma.
Chen KH; He J; Wang DL; Cao JJ; Li MC; Zhao XM; Sheng X; Li WB; Liu WJ
Int J Oncol; 2014 Dec; 45(6):2511-21. PubMed ID: 25270913
[TBL] [Abstract][Full Text] [Related]
8. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.
Ahn EY; Kim JS; Kim GJ; Park YN
Mol Cancer Res; 2013 Jul; 11(7):748-58. PubMed ID: 23594797
[TBL] [Abstract][Full Text] [Related]
9. Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease.
Tarris G; de Rougemont A; Estienney M; Charkaoui M; Mouillot T; Bonnotte B; Michiels C; Martin L; Belliot G
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441404
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2.
Roßwag S; Sleeman JP; Thaler S
Cells; 2021 Oct; 10(11):. PubMed ID: 34831091
[TBL] [Abstract][Full Text] [Related]
11. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.
Wang C; Zhu ZM; Liu CL; He XJ; Zhang HY; Dong JH
Mol Med Rep; 2015 Jun; 11(6):4101-8. PubMed ID: 25625370
[TBL] [Abstract][Full Text] [Related]
13. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.
Guo C; Tommasi S; Liu L; Yee JK; Dammann R; Pfeifer GP
Curr Biol; 2007 Apr; 17(8):700-5. PubMed ID: 17379520
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.
Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G
Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982
[TBL] [Abstract][Full Text] [Related]
16. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.
Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H
J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
19. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
20. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
